Cancers, Vol. 12, Pages 1203: Inhibition of HIF-1 α by Atorvastatin During 131I-RTX Therapy in Burkitt’s Lymphoma Model

Conclusion: Our findings suggested that combination therapy with ATV and 131I-RTX is a promising strategy for enhancing the potency of 131I-RTX therapy in poorly responding patients and those with radio-resistance.

Source: Cancers - May 10, 2020 Category: Cancer & Oncology Authors: Eun-Ho Kim Hae Young Ko A Ram Yu Hyeongi Kim Javeria Zaheer Hyun Ji Kang Young-Cheol Lim Kyung Deuk Cho Hyun-Yoo Joo Min Kyoung Kang Jae Jun Lee Seung-Sook Lee Hye Jin Kang Sang Moo Lim Jin Su Kim Tags: Article Source Type: research